FDA recall, , Moderate risk
American Red Cross Apheresis Platelets and Red Blood Cells
American Red Cross Apheresis Platelets and Red Blood Cells, for which Babesia testing was not performed, were distributed.
Recall ended Feb 11, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
American Red Cross Norfolk Main Site recalled Red Blood Cells, Apheresis Platelets, and Apheresis Red Blood Cells, including irradiated versions, because Babesia testing was not performed. The products were distributed in Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia. The recall began May 10, 2023, and was classified by the FDA on February 11, 2026.
3 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
5 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Reason: Apheresis Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed.
- Affected units
- W202923166224006 (double collection); W20292214056300Y (double collection); W20292214056700Q (double collection)
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed.
Apheresis Platelets, PAS, Leukocytes Reduced
Reason: Apheresis Platelets, PAS, Leukocytes Reduced, for which Babesia testing was not performed, were distributed.
- Affected units
- W20292084804500H (double collection); W20292085063900O; W20292084804400J; W20292085063500W; W20292085063700S; W20292085063800Q (triple collection); W20292085437000N (triple collection); W20292085520400Z (triple collection)
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, for which Babesia testing was not performed, were distributed.
Apheresis Platelets, PAS, Leukocytes Reduced, Irradiated
Reason: Apheresis Platelets, PAS, Leukocytes Reduced, Irradiated, for which Babesia testing was not performed, were distributed.
Recall details
- Company began the recall
- Sold in
- 6 states
- Company
- American Red Cross Norfolk Main Site
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98421
- Recall numbers
- B-0022-2026 to B-0026-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
